Tudor Investment Corp
TBIO

Tudor Investment Corp’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Tudor Investment Corp’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,214
Closed -$430K – 2816
2021
Q4 		$430K Sell
2,214
-283
-11% -$44K 0.01% 1581
2021
Q3 		$500K Sell
2,497
-281
-10% -$71.3K 0.01% 1652
2021
Q2 		$1.1M Buy
+2,778
New +$982K 0.02% 825

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tudor Investment Corp's TBIO Position: Q1 2022 in Review

Tudor Investment Corp sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022, closing a stake of 2,214 shares — an estimated $430K sold.

Tudor Investment Corp first reported a position in TBIO in Q2 2021 and held it in 3 quarters. The position peaked at $1.1M in Q2 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • Tudor Investment Corp reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 2,214 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $430K.
  • Tudor Investment Corp first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Tudor Investment Corp's Telesis Bio, Inc. Common Stock position peaked at $1.1M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.